Childrens Hospital Boston, Dana-Farber Cancer Institute.

Boston, Massachusetts 02215

1 studies enrolling now · 10 studies all time

What they study most

Brain Tumors, Ewing's Sarcoma Family of Tumors, Neuroblastoma, Osteosarcoma, Rhabdomyosarcoma and Other Soft Tissue Sarcomas

Studies at this site

• Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells — Running, not enrolling
• Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma — Running, not enrolling
• Neuroblastoma Precision Trial — Running, not enrolling
• NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab — Starting soon
• NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922) — Completed
• N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan — Completed
• N99-02: Melphalan and Buthionine Sulfoximine — Completed
• Study of MLN8237 in Combination With Irinotecan and Temozolomide — Completed
• SF1126 for Patients With Relapsed or Refractory Neuroblastoma — Stopped early
• Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors — Completed